| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S11920-018-0872-4 |
| P698 | PubMed publication ID | 29504088 |
| P50 | author | Daniel J. Clauw | Q60302008 |
| P2093 | author name string | Jenna Goesling | |
| Lewei A Lin | |||
| P2860 | cites work | Opioid agonist treatment for pharmaceutical opioid dependent people | Q24185775 |
| Opioids compared to placebo or other treatments for chronic low-back pain | Q24200220 | ||
| Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence | Q24200539 | ||
| Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects. | Q24547899 | ||
| Opioid Abuse in Chronic Pain--Misconceptions and Mitigation Strategies | Q26749305 | ||
| Antidepressants as analgesics: a review of randomized controlled trials | Q28352223 | ||
| Understanding fibromyalgia: lessons from the broader pain research community | Q30480264 | ||
| Treatment of fibromyalgia with antidepressants: a meta-analysis. | Q30940465 | ||
| Opioids in chronic non-cancer pain: systematic review of efficacy and safety | Q31131499 | ||
| Systematic review and meta-analysis of randomized controlled trials of cognitive behaviour therapy and behaviour therapy for chronic pain in adults, excluding headache | Q33594776 | ||
| Depression and pain comorbidity: a literature review | Q33973797 | ||
| Decreased central mu-opioid receptor availability in fibromyalgia. | Q34006935 | ||
| Risks for opioid abuse and dependence among recipients of chronic opioid therapy: results from the TROUP study | Q34258923 | ||
| The role of antidepressants in the management of fibromyalgia syndrome: a systematic review and meta-analysis | Q34263924 | ||
| Pleasure into pain: the consequences of long-term opioid use. | Q34345479 | ||
| The relationship between depression, clinical pain, and experimental pain in a chronic pain cohort | Q34417055 | ||
| Resting state connectivity correlates with drug and placebo response in fibromyalgia patients | Q34432234 | ||
| Increasing deaths from opioid analgesics in the United States | Q34550465 | ||
| Pharmacotherapy of chronic pain: a synthesis of recommendations from systematic reviews | Q34607193 | ||
| Evidence of prescription of antidepressants for non-psychiatric conditions in primary care: an analysis of guidelines and systematic reviews | Q34704481 | ||
| The relationship between fibromyalgia and interstitial cystitis | Q34741197 | ||
| Reciprocal relationship between pain and depression: a 12-month longitudinal analysis in primary care | Q35568344 | ||
| The epidemiology of pain in depression | Q35892386 | ||
| Depression and prescription opioid misuse among chronic opioid therapy recipients with no history of substance abuse | Q36083505 | ||
| Pain symptoms in depression: definition and clinical significance | Q36247241 | ||
| Idiopathic pain disorders--pathways of vulnerability. | Q36507760 | ||
| Prescription drug abuse: what is being done to address this new drug epidemic? Testimony before the Subcommittee on Criminal Justice, Drug Policy and Human Resources | Q36635065 | ||
| Prescribed opioid difficulties, depression and opioid dose among chronic opioid therapy patients. | Q36880782 | ||
| Treating the physical symptoms of depression with second-generation antidepressants: a systematic review and metaanalysis | Q37151683 | ||
| Buprenorphine/naloxone as a promising therapeutic option for opioid abusing patients with chronic pain: reduction of pain, opioid withdrawal symptoms, and abuse liability of oral oxycodone | Q37164033 | ||
| Trends in long-term opioid therapy for noncancer pain among persons with a history of depression | Q37415587 | ||
| Advances in the assessment of fibromyalgia | Q37568734 | ||
| Prescription drug overdoses: a review | Q38057860 | ||
| The missing 'P' in pain management: how the current opioid epidemic highlights the need for psychiatric services in chronic pain care | Q38161209 | ||
| Patient-reported pathways to opioid use disorders and pain-related barriers to treatment engagement | Q39162177 | ||
| Risk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic non-cancer pain | Q39336467 | ||
| Critical issues on opioids in chronic non-cancer pain: an epidemiological study | Q39348642 | ||
| The concept of affective spectrum disorder: relationship to fibromyalgia and other syndromes of chronic fatigue and chronic muscle pain | Q40589766 | ||
| Chronic pain-associated depression: antecedent or consequence of chronic pain? A review | Q41499997 | ||
| Symptoms of Depression Are Associated With Opioid Use Regardless of Pain Severity and Physical Functioning Among Treatment-Seeking Patients With Chronic Pain | Q41665375 | ||
| Elevated excitatory neurotransmitter levels in the fibromyalgia brain | Q42345705 | ||
| Managing Chronic Pain in Primary Care: It Really Does Take a Village | Q43595433 | ||
| Association between mental health disorders, problem drug use, and regular prescription opioid use. | Q44332557 | ||
| Association of mental health disorders with prescription opioids and high-risk opioid use in US veterans of Iraq and Afghanistan. | Q44333235 | ||
| A cross-national study of the course of persistent pain in primary care | Q44353553 | ||
| The complex interplay between pain intensity, depression, anxiety and catastrophising with respect to quality of life and disability | Q45417580 | ||
| Longitudinal relationships among pain, sleep problems, and depression in rheumatoid arthritis | Q46325825 | ||
| Relationships among depression, chronic pain, chronic disabling pain, and medical costs | Q46544453 | ||
| Regular use of prescribed opioids: association with common psychiatric disorders | Q46812037 | ||
| Comorbid depression, chronic pain, and disability in primary care | Q46857429 | ||
| A randomized trial of a pain management intervention for adults receiving substance use disorder treatment | Q48063972 | ||
| Conditioned pain modulation predicts duloxetine efficacy in painful diabetic neuropathy. | Q48703400 | ||
| Depression: relationship to somatization and chronic medical illness. | Q51234782 | ||
| Comorbid chronic pain and depression: who is at risk? | Q51642005 | ||
| Antecedent nonbladder syndromes in case-control study of interstitial cystitis/painful bladder syndrome. | Q51674916 | ||
| Prevalence, onset, and risk of psychiatric disorders in men with chronic low back pain: a controlled study | Q52050672 | ||
| Pain catastrophizing and neural responses to pain among persons with fibromyalgia | Q56136269 | ||
| Pregabalin Rectifies Aberrant Brain Chemistry, Connectivity, and Functional Response in Chronic Pain Patients | Q60691571 | ||
| Abnormal magnetic-resonance scans of the lumbar spine in asymptomatic subjects. A prospective investigation | Q68726711 | ||
| Prospective study on the relationship between depressive symptoms and chronic musculoskeletal pain | Q72040168 | ||
| Widespread pain in fibromyalgia is related to a deficit of endogenous pain inhibition | Q81446244 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | psychiatry | Q7867 |
| mental health | Q317309 | ||
| pain management | Q621261 | ||
| chronic pain | Q1088113 | ||
| P304 | page(s) | 12 | |
| P577 | publication date | 2018-03-05 | |
| P1433 | published in | Current Psychiatry Reports | Q25245507 |
| P1476 | title | Psychiatry and Pain Management: at the Intersection of Chronic Pain and Mental Health. | |
| P478 | volume | 20 |
| Q64111902 | Cutting-Edge Search for Safer Opioid Pain Relief: Retrospective Review of Salvinorin A and Its Analogs |
| Q60956577 | Manganese-Enhanced Magnetic Resonance Imaging: Overview and Central Nervous System Applications With a Focus on Neurodegeneration |
| Q64241774 | Opioid Prescriptions at Hospital Discharge Are Associated With More Postdischarge Healthcare Utilization |
| Q56243456 | Prodrome and Non-prodrome Phenotypes of Bladder Pain Syndrome/Interstitial Cystitis |
| Q97880345 | Psychological morbidity among adults with cerebral palsy and spina bifida |
| Q58087322 | Psychology of Chronic Pelvic Pain: Prevalence, Neurobiological Vulnerabilities, and Treatment |
Search more.